Healthcare provider profile · identity verified

Mark A. Krawiec, MD

Internal Medicine · LINCOLN, CA · NPI 1639257132

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	521	167
Amlodipine Besylate	Amlodipine Besylate	452	155
Levothyroxine Sodium	Levothyroxine Sodium	401	117
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	328	52
Losartan Potassium	Losartan Potassium	303	107
Lisinopril	Lisinopril	207	72
Tamsulosin Hcl	Tamsulosin Hcl	179	60
Simvastatin	Simvastatin	168	50
Trazodone Hcl	Trazodone Hcl	167	44
Metoprolol Succinate	Metoprolol Succinate	162	53
Metoprolol Tartrate	Metoprolol Tartrate	162	55
Pantoprazole Sodium	Pantoprazole Sodium	155	53
Gabapentin	Gabapentin	153	50
Furosemide	Furosemide	151	57
Fluticasone Propionate	Fluticasone Propionate	147	61
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	146	47
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	146	48
Albuterol Sulfate Hfa	Albuterol Sulfate	137	68
Potassium Chloride	Potassium Chloride	136	50
Hydrochlorothiazide	Hydrochlorothiazide	132	50
Lorazepam	Lorazepam	132	26
Metformin Hcl Er	Metformin Hcl	112	38
Ozempic	Semaglutide	107	21
Prednisone	Prednisone	105	65
Famotidine	Famotidine	104	39
Ibuprofen	Ibuprofen	103	45
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	100	21
Atenolol	Atenolol	98	35
Rosuvastatin Calcium	Rosuvastatin Calcium	96	34
Omeprazole	Omeprazole	95	42
Breyna	Budesonide/Formoterol Fumarate	87	23
Duloxetine Hcl	Duloxetine Hcl	87	32
Meloxicam	Meloxicam	87	23
Ondansetron Hcl	Ondansetron Hcl	84	11
Sertraline Hcl	Sertraline Hcl	75	25
Clopidogrel	Clopidogrel Bisulfate	72	24
Triamcinolone Acetonide	Triamcinolone Acetonide	72	37
Allopurinol	Allopurinol	71	23
Lovastatin	Lovastatin	71	25
Carvedilol	Carvedilol	64	21
Tizanidine Hcl	Tizanidine Hcl	62	18
Metformin Hcl	Metformin Hcl	61	19
Doxycycline Monohydrate	Doxycycline Monohydrate	60	44
Jardiance	Empagliflozin	60	21
Ipratropium Bromide	Ipratropium Bromide	58	20
Terazosin Hcl	Terazosin Hcl	58	16
Pradaxa	Dabigatran Etexilate Mesylate	56	22
Donepezil Hcl	Donepezil Hcl	53	15
Mirtazapine	Mirtazapine	51	15
Temazepam	Temazepam	51	11
Escitalopram Oxalate	Escitalopram Oxalate	50	18
Warfarin Sodium	Warfarin Sodium	50	16
Glimepiride	Glimepiride	48	16
Baclofen	Baclofen	45	suppressed
Cefadroxil	Cefadroxil	44	33
Pregabalin	Pregabalin	44	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	43	suppressed
Montelukast Sodium	Montelukast Sodium	43	suppressed
Alvesco	Ciclesonide	41	15
Finasteride	Finasteride	40	13
Citalopram Hbr	Citalopram Hydrobromide	39	11
Acyclovir	Acyclovir	38	16
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	38	suppressed
Trospium Chloride	Trospium Chloride	38	13
Venlafaxine Hcl Er	Venlafaxine Hcl	38	11
Clonazepam	Clonazepam	37	suppressed
Glipizide	Glipizide	37	13
Eliquis	Apixaban	36	11
Spironolactone	Spironolactone	36	16
Lactulose	Lactulose	35	suppressed
Morphine Sulfate Er	Morphine Sulfate	35	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	29
Oxycodone Hcl	Oxycodone Hcl	34	suppressed
Tramadol Hcl	Tramadol Hcl	34	13
Wixela Inhub	Fluticasone Propion/Salmeterol	34	suppressed
Xarelto	Rivaroxaban	33	suppressed
Alendronate Sodium	Alendronate Sodium	32	14
Ciclopirox	Ciclopirox	32	20
Pravastatin Sodium	Pravastatin Sodium	32	11
Clobetasol Propionate	Clobetasol Propionate	31	19
Nystatin	Nystatin	31	22
Spiriva Respimat	Tiotropium Bromide	31	12
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	29	12
Colestipol Hcl	Colestipol Hcl	28	suppressed
Hydrocortisone	Hydrocortisone	27	15
Zolpidem Tartrate	Zolpidem Tartrate	27	suppressed
Cephalexin	Cephalexin	26	17
Azithromycin	Azithromycin	25	20
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	21
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Amoxicillin	Amoxicillin	22	16
Azelastine Hcl	Azelastine Hcl	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	11
Humulin N	Insulin Nph Human Isophane	21	suppressed
Ketoconazole	Ketoconazole	21	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	19
Colchicine	Colchicine	20	suppressed
Fluconazole	Fluconazole	20	suppressed
Fluocinonide	Fluocinonide	20	11
Primidone	Primidone	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	18	suppressed
Midodrine Hcl	Midodrine Hcl	18	suppressed
Naproxen	Naproxen	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Veo Insulin Syringe	Syrge-Ndl,ins 0.3 Ml Half Mark	17	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Risperidone	Risperidone	16	suppressed
Topiramate	Topiramate	16	suppressed
Valsartan	Valsartan	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Divalproex Sodium	Divalproex Sodium	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Eplerenone	Eplerenone	14	suppressed
Estradiol	Estradiol	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Oxazepam	Oxazepam	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Erythromycin	Erythromycin Base	13	11
Lamotrigine	Lamotrigine	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	12	12
Digoxin	Digoxin	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	12	11
Azelaic Acid	Azelaic Acid	11	suppressed
Econazole Nitrate	Econazole Nitrate	11	suppressed
Flunisolide	Flunisolide	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error